Published in Am J Health Promot on September 28, 1995
Preventing chronic disease in the workplace: a workshop report and recommendations. Am J Public Health (2011) 1.44
Pausa para tu Salud: reduction of weight and waistlines by integrating exercise breaks into workplace organizational routine. Prev Chronic Dis (2007) 1.04
A pilot study of increasing nonpurposeful movement breaks at work as a means of reducing prolonged sitting. J Environ Public Health (2013) 0.95
Mail and phone interventions for weight loss in a managed-care setting: Weigh-To-Be one-year outcomes. Int J Obes Relat Metab Disord (2003) 2.31
Identifying diabetes mellitus or heart disease among health maintenance organization members: sensitivity, specificity, predictive value, and cost of survey and database methods. Am J Manag Care (1998) 1.93
Screening for diabetes mellitus in high-risk patients: cost, yield, and acceptability. Eff Clin Pract (2001) 1.80
Binge eating disorder, weight control self-efficacy, and depression in overweight men and women. Int J Obes Relat Metab Disord (2004) 1.68
Mail and phone interventions for weight loss in a managed-care setting: weigh-to-be 2-year outcomes. Int J Obes (Lond) (2006) 1.42
Response of pancreatic beta-cells to improved insulin sensitivity in women at high risk for type 2 diabetes. Diabetes (2000) 1.31
EUS-guided single-incision needle-knife biopsy: description and results of a new method for tissue sampling of subepithelial GI tumors (with video). Gastrointest Endosc (2011) 1.25
Health promotion programs, modifiable health risks, and employee absenteeism. J Occup Environ Med (2001) 1.16
Abnormal verbal event related potentials in mild cognitive impairment and incipient Alzheimer's disease. J Neurol Neurosurg Psychiatry (2002) 1.13
Synthesis and antiprotozoal properties of 1,2,6-thiadiazine 1,1-dioxide derivatives. Arch Pharm (Weinheim) (1992) 1.12
Physical inactivity and short-term all-cause mortality in adults with chronic disease. Arch Intern Med (2001) 1.06
Weight loss goals and treatment outcomes among overweight men and women enrolled in a weight loss trial. Int J Obes (Lond) (2005) 1.04
Does professional advice influence aspirin use to prevent heart disease in an HMO population? Eff Clin Pract (1999) 1.03
Implications of an AHEC library program evaluation: considerations for small rural hospitals. Bull Med Libr Assoc (1985) 0.99
Prescription of exercise intensity for the obese patient: the relationship between heart rate, VO2 and perceived exertion. Int J Obes Relat Metab Disord (1995) 0.95
Integrating population health concepts, clinical guidelines, and ambulatory medical systems to improve diabetes care. J Ambul Care Manage (1998) 0.94
Professional advice and readiness to change behavioral risk factors among members of a managed care organization. Am J Manag Care (2001) 0.91
Acute lymphoblastic leukemia associated with RCSD1-ABL1 novel fusion gene has a distinct gene expression profile from BCR-ABL1 fusion. Leukemia (2012) 0.90
Fertility and contraception of 6 patients with ovarian pregnancy. Int J Fertil (1984) 0.87
Executive functioning among female pathological gambling and bulimia nervosa patients: preliminary findings. J Int Neuropsychol Soc (2009) 0.87
Stages of change for physical activity, diet, and smoking among HMO members with chronic conditions. Am J Health Promot (1998) 0.86
[Practice variation and appropriateness study of antimicrobial therapy for acute pharyngotonsillitis in adults]. Enferm Infecc Microbiol Clin (1999) 0.85
The comparative and cumulative effects of a dietary restriction and exercise on weight loss. Int J Obes (Lond) (2006) 0.84
Effects of a very-low-calorie diet and physical-training regimens on body composition and resting metabolic rate in obese females. Am J Clin Nutr (1991) 0.84
The role of the certified diabetes educator in telephone counseling. Diabetes Educ (2002) 0.83
Incidence and prevalence of type 1 diabetes in children aged <15 yr in Castilla-Leon (Spain). Pediatr Diabetes (2007) 0.82
Study on the decomposition products of thiadiazinthione and their anticancer properties. Arzneimittelforschung (2000) 0.80
The variability and appropriateness of the antibiotic prescription of acute otitis media in childhood. The Spanish Study Group for Antibiotic Treatments. Int J Pediatr Otorhinolaryngol (2000) 0.79
Tolerances of wild potato species from different altitudes to cold and heat. Planta (1983) 0.77
Early- and late-stage breast cancer in a managed care setting in relation to mammography screening. Cancer Detect Prev (1998) 0.77
New thiadiazine derivatives with activity against Trypanosoma cruzi amastigotes. Folia Parasitol (Praha) (2001) 0.76
17 beta-Hydroxysteroid dehydrogenase activity in human breast epithelial cell and fibroblast cultures. Endocrinology (1984) 0.76
Activity assays of thiadiazine derivatives on Trichomonas vaginalis and amastigote forms of Trypanosoma cruzi. Chemotherapy (1992) 0.76
Highly active antiretroviral therapy does not protect against Kaposi's sarcoma in HIV-infected individuals. AIDS (2000) 0.75
Minor hemoglobin components in diabetic and uremic patients. Horm Metab Res (1981) 0.75
Simultaneous measurement of beta-endorphin, lipotrophins and met-enkephalin in phaeochromocytomas. Acta Endocrinol (Copenh) (1982) 0.75
Synthesis and antichagasic properties of new 1,2,6-thiadiazin-3,5-dione 1,1-dioxides and related compounds. Arzneimittelforschung (1999) 0.75
Effect of Somatostatin on TSH levels in non-toxic sporadic goiter. Horm Metab Res (1990) 0.75
[Workload analysis in a clinical laboratory]. Enferm Infecc Microbiol Clin (1999) 0.75
3,5-Diamino-1,2,6-thiadiazine 1,1-dioxide derivatives: synthesis and antiparasitic activity. Farmaco Sci (1986) 0.75
Dopamine interaction in the absence and in the presence of Cu2+ ions with macrocyclic and macrobicyclic polyamines containing pyrazole units. Crystal structures of [Cu2(L1)(H2O)2](ClO4)4 and [Cu2(H-1L3)](ClO4)3*2H2O. J Am Chem Soc (2001) 0.75
Database system to identify biological risk in managed care organizations: implications for clinical care. J Ambul Care Manage (1997) 0.75
Imidazothiadiazine dioxides: synthesis and antiviral activity. Bioorg Med Chem (1999) 0.75
Anthelmintic activity of pyrazinothiadiazine dioxide derivatives. Arzneimittelforschung (1993) 0.75
[Idiopathic perforation of the choledocus in childhood]. An Esp Pediatr (1987) 0.75
In vitro effects of anti-Trypanosoma cruzi compounds on HSP60 levels. Parasitol Res (2001) 0.75
[Fasting and postprandial lipids and lipoproteins during the chronic administration of antihypertensive drugs]. Arch Inst Cardiol Mex (1995) 0.75
Cost analysis in a clinical microbiology laboratory. Eur J Clin Microbiol Infect Dis (2002) 0.75
[General anaesthesia and obstetric bleeding in caesarean section. One year's experience in a university hospital]. Rev Esp Anestesiol Reanim (2012) 0.75
[Independent predictive factors of acute and first year success after electrical cardioversion in patients with chronic atrial fibrillation]. Rev Esp Cardiol (2001) 0.75
[Membranous glomerulonephritis. Experience at the Instituto Nacional de la Nutrición Salvador Zubirán]. Rev Invest Clin (1991) 0.75
[Multicenter study of the variability and adequacy of antimicrobial therapy for community-acquired pneumonia in adults]. Rev Esp Quimioter (1999) 0.75